Colorectal Neuroendocrine Tumor — Trials

Colorectal Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT07759960	Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors	recruiting	N/A	174	Nanfang Hospital, Southern Medical UniversityOTHER	1	Aug 12, 2026	clinicaltrials
NCT07612748	Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms	recruiting	N/A	483	Jilin UniversityOTHER	1	Jun 3, 2026	clinicaltrials
NCT07373015

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials